Brachytherapy
Volume 8, Issue 3 , Pages 290-296 , July 2009

125I episcleral plaque brachytherapy in the treatment of choroidal melanoma: A single-institution experience in Spain

  • Raquel Correa

      Affiliations

    • Department of Radiation Oncology, Hospital Clínico Universitario Virgen de la Victoria, Málaga, Spain
    • Corresponding Author InformationCorresponding author. Department of Radiation Oncology, Hospital Clínico Universitario Virgen de la Victoria, Campus Universitario de Teatinos s/n, 29010 Málaga. Spain. Tel.: +34-951032617; fax: +34-952279407.
    • ,
  • Joan Pera

      Affiliations

    • Department of Radiation Oncology, Catalan Institute of Oncology, Barcelona, Spain
    • ,
  • Joaquín Gómez

      Affiliations

    • Department of Radiation Oncology, CROASA Clinic, Málaga, Spain
    • ,
  • Alfredo Polo

      Affiliations

    • Department of Radiation Oncology, Hospital Ramon y Cajal, Madrid, Spain
    • ,
  • Cristina Gutiérrez

      Affiliations

    • Department of Radiation Oncology, Catalan Institute of Oncology, Barcelona, Spain
    • ,
  • Josep María Caminal

      Affiliations

    • Department of Ophthalmology, Hospital Universitario de Bellvitge, Barcelona, Spain
    • ,
  • Ignasi Modolell

      Affiliations

    • Department of Medical Physics, Catalan Institute of Oncology, Barcelona, Spain
    • ,
  • Valenti Navarro

      Affiliations

    • Clinical Research Unit, Catalan Institute of Oncology, Barcelona, Spain
    • ,
  • Ferrán Guedea

      Affiliations

    • Department of Radiation Oncology, Catalan Institute of Oncology, Barcelona, Spain

Received 9 July 2008 ,Revised 15 March 2009 ,Accepted 17 March 2009.

References 

  1. Zimmerman LE, McLean IW, Foster WD. Does enucleation of the eye containing a malignant melanoma prevent or accelerate the dissemination of tumour cells?. Br J Ophthalmol. 1978;62:420–425
  2. Curtis E. The Collaborative Ocular Melanoma Study: An overview. Cancer Control. 2004;11:304–3091
  3. Gass JD. Comparison of prognosis after enucleation vs cobalt 60 irradiation of melanomas. Arch Ophthalmol. 1985;103:916–923
  4. Cruess AF, Augsburger JJ, Shields JA, et al. Regression of posterior uveal melanomas following cobalt-60 plaque radiotherapy. Ophthalmology. 1984;91:1716–1719
  5. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma II: Initial mortality findings. COMS report No. 10. Am J Ophthalmol. 1998;125:779–796
  6. Diener-West M, Earle JD, Fine SL, et al. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma III: Initial mortality findings. COMS report No. 18. Arch Ophthalmol. 2001;119:969–982
  7. The Collaborative Ocular Melanoma Study Group. Factors predictive of growth and treatment of small choroidal elanoma: COMS report No. 5. Arch Ophthalmol. 1997;115:1537–1544
  8. Jensen AW, Petersen IA, Kline RW, et al. Radiation complications and tumor control after 125I plaque brachytherapy for ocular melanoma. Int J Radiat Oncol Biol Phys. 2005;63:101–108
  9. De Potter P, Shields CL, Shields JA, et al. Plaque radiotherapy for juxtapapillary choroidal melanoma. Visual acuity and survival outcome. Arch Ophthalmol. 1996;114:1357–1365
  10. Gunduz K, Shields CL, Shields JA, et al. Radiation complications and tumor control after plaque radiotherapy of choroidal melanoma with macular involvement. Am J Ophthalmol. 1999;127:579–589
  11. Shields CL, Naseripour M, Cater J, et al. Plaque radiotherapy for large posterior uveal melanomas (≥8 mm thick) in 354 consecutive patients. Ophthalmology. 2002;109:1838–1849
  12. Heindl LM, Lotter M, Strnad V, et al. High-dose (106)Ruthenium plaque brachytherapy for posterior uveal melanoma: A clinico-pathologic study. Ophthalmologe. 2007;104:149–157
  13. Damato B, Patel I, Campbell I, et al. Local tumor control after 106Ru brachytherapy of choroidal melanoma. Int J Radiat Oncol Biol Phys. 2005;63:385–391
  14. Petrovich Z, Luxton G, Langholz B, et al. Episcleral plaque radiotherapy in the treatment of uveal melanomas. Int J Radiat Oncol Biol Phys. 1992;24:247–251
  15. Jampol LM, Moy CS, Murray TG, et al. Collaborative Ocular Melanoma Study Group (COMS Group) The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report no. 19. Ophthalmology. 2002;109:2197–2206
  16. Collaborative Ocular Melanoma Study Group. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report No. 28. Arch Ophthalmol. 2006;124:1684–1693
  17. Nag S, Wang D, Wu H, et al. Custom-made “Nag” eye plaques for 125I brachytherapy. Int J Radiat Oncol Biol Phys. 2003;56:1373–1380
  18. Moataz N, El-Ghamry MD, Subir Nag MD, et al. Results of primary treatment of small or medium sized uveal melanoma with custom-made Nag iodine-125 eye plaque: The Ohio State University experience with 119 patients. Brachytherapy. 2006;5:90
  19. Fontanesi J, Meyer D, Xu S, et al. Treatment of choroidal melanoma with I-125 plaque. Int J Radiat Oncol Biol Phys. 1993;26:619–623
  20. Packer S, Stoller S, Lesser ML, et al. Long-term results of iodine 125 irradiation of uveal melanoma. Ophthalmology. 1992;99:767–774
  21. Collaborative Ocular Melanoma Study Group. The Collaborative Ocular Melanoma Study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma. Visual acuity after 3 years. COMS Report No 16. Ophthalmology. 2001;108:348–366
  22. Caminal JM, Quintana M, Pera J, et al. Results of iodine-125 radiotherapy in the treatment of uveal melanoma. Arch Soc Esp Oftalmol. 2002;77:29–38

PII: S1538-4721(09)00197-4

doi: 10.1016/j.brachy.2009.03.189

Brachytherapy
Volume 8, Issue 3 , Pages 290-296 , July 2009

Article Tools

* Image Usage & Resolution